GUGGENHEIM CAPITAL LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 156 filers reported holding ANIKA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$234,000
-6.8%
4,779
-8.9%
0.00%0.0%
Q3 2016$251,000
-13.7%
5,244
-3.4%
0.00%0.0%
Q2 2016$291,000
+22.8%
5,430
+2.7%
0.00%0.0%
Q1 2016$237,000
-86.0%
5,289
-90.1%
0.00%
-80.0%
Q3 2015$1,693,000
-2.7%
53,201
+1.0%
0.01%
+25.0%
Q2 2015$1,740,000
+7.7%
52,662
+34.2%
0.00%0.0%
Q1 2015$1,615,000
+27.2%
39,251
+25.9%
0.00%
+33.3%
Q4 2014$1,270,000
+4.2%
31,182
-6.2%
0.00%0.0%
Q3 2014$1,219,000
-35.0%
33,239
-17.9%
0.00%
-40.0%
Q2 2014$1,874,000
+0.1%
40,462
-11.2%
0.01%0.0%
Q1 2014$1,872,000
-19.0%
45,545
-24.8%
0.01%
-28.6%
Q4 2013$2,310,00060,5350.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders